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Background: Osteoarthritis is a leading cause of disability in developed nations. In Australia it afflicts 16.5% of the
adult population. Total joint arthroplasty is considered the treatment of choice for end stage osteoarthritis. The
number of total joint arthroplasties undertaken in Australia has doubled over the last decade (more than 80,000
procedures in 2011). The incidence of pre-operative psychological distress in this group of patients is reported
between 30% and 60% and pre-operative psychological distress is associated with poorer pain and functional
outcomes after surgery. This study will use a mindfulness-based psychological intervention to enhance outcomes in
people undergoing total joint arthroplasty and, in addition, will test hypotheses about coping with chronic illness in
an aged population. This study is the first of its kind and will provide a greater understanding of the role of a
mental health enhancement program on the physical recovery of total joint arthroplasty patients.
Methods/Design: One hundred and fifty people with end-stage arthritis on the waiting list for total hip or knee
arthroplasty will be recruited and randomly allocated to one of two groups using computer-generated block
randomisation. A randomised controlled trial adhering to CONSORT guidelines will evaluate the efficacy of a
mindfulness training program (weekly group-based classes in mindfulness practice, 2 ½ hours, for 8 weeks plus a
7-hour Saturday session in Week 6) prior to total joint arthroplasty, compared to a “standard care” group who will
undergo routine total joint arthroplasty. Primary outcomes will be evaluated by a blinded examiner at baseline,
3 and 12 months post-surgery, using a validated self-reported pain and physical function scale. Secondary outcomes
will include i) a range of validated measures of psychological wellbeing and ii) health economic analysis. All analyses
will be conducted on an intention to treat basis using linear regression models. Health economic modelling will be
applied to estimate the potential cost-effectiveness of mindfulness training and total joint arthroplasty.
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTRN12611001184965). Date of registration;
15th November 2011.
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Osteoarthritis is a leading cause of disability in devel-
oped nations. In Australia, it afflicts 16.5% of the adult
population and imposes a significant economic burden
[1]. Total joint arthroplasty (TJA) is considered the treat-
ment of choice for end-stage osteoarthritis. However, the
success of TJA, a high volume, expensive procedure, is
undermined by pre-operative psychological distress, a
known predictor of suboptimal improvement after sur-
gery. Psychological co-morbidities and traits reported in
TJA patients include depression, anxiety, neuroticism,
catastrophizing, poor self-esteem, and low self-efficacy,
all of which are associated with poorer function and
greater pain after TJA in short and longer term follow-up
studies [2-7].
Our recent comprehensive literature review found pre-
operative psychological distress to be an independent
predictor of pain and function after TJA in a majority of
published studies [8]. This relationship has also been noted
for other major surgical procedures, e.g., herniated disc
surgery [9] and coronary artery bypass graft surgery [10].
In a large prospective study involving more than 1,000 TJA
recipients, we showed that poorer pre-operative mental
health scores were associated with weight gain after sur-
gery [11]. Obesity is over-represented in TJA candidates
(hip patients > 40% obese, knee > 60%) and only 10% show
clinically significant weight loss after surgery [11,12]; obes-
ity itself is strongly associated with depression [13]. Pre-
operative psychological distress is also associated with
excessive analgesic intake, higher rates of hospital re-
admission, and long-erm mortality [14].
Despite such findings, there is a dearth of literature
examining psychological interventions or programs in sur-
gical patients generally, and, to the best of our knowledge,
there are no published intervention studies specifically for
TJA. Thus, there is a pressing need to examine whether
implementing a mental health enhancement program im-
proves postoperative outcomes in patients undergoing
TJA, a question with relevance to other surgical programs
and to the health of the aged more generally.
Mindfulness training (MT) is derived mainly from
Eastern-based philosophical traditions, with mindfulness-
based concepts and therapies widely incorporated into
experimental and clinical psychology and psychiatry in
the past 30 years [15]. Although there is a spectrum of
mindfulness-related concepts, we adopt the definition of
Kabat-Zinn, where mindfulness is “the awareness that
emerges through paying attention on purpose, in the present
moment, and non-judgmentally to the unfolding of experi-
ence moment by moment” [16] (p. 145). This is the basis of
an approach known as “mindfulness-based stress reduc-
tion” (which we will here refer to as MT for the sake of
brevity), the approach employed in most studies of physical
health conditions [15].Benefits of MT have been demonstrated for psychiatric
disorders [15,17] and in stressed healthy cohorts [18],
but of most relevance to this proposal is its use in older
adults [19] and in patients with physically debilitating
conditions such as multiple sclerosis [20], fibromyalgia
[21], arthritis [22], and chronic pain [23]. Randomised
controlled trials in pain patients show efficacy for psy-
chological distress (in general and for symptoms of de-
pression and anxiety in particular), for health related
quality of life, as well as for fatigue, pain, functioning,
and somatic complaints. Most studies show low attrition
(15%) [24] and sustained improvements (particularly in
functioning) at up to 3 years [15]. Most psychological in-
terventions for physically ill subjects have arisen out of
psychotherapies for the mentally ill (notably cognitive
behaviour therapy). In contrast, MT is useful in dis-
tressed patients who do not necessarily meet diagnostic
criteria for mental illness [25].
Keeping in mind the absence of previously established
psychological interventions in arthroplasty, we propose
that MT prior to TJA is likely to be a particularly suit-
able and effective intervention, leading to better out-
comes. The primary aim of this research is to determine
if psychological well-being and physical recovery are im-
proved in TJA patients if surgery is preceded by a men-
tal health enhancement program. Two exploratory aims
of this study will be: i) to compare the cost effectiveness
of this combination versus standard of care; ii) to inves-
tigate the influence of mindfulness training on candidate
mediators of health outcomes drawn from psychological
research on adaptation to illness–notably cognitive dis-
tortions, illness beliefs, and coping styles.
Methods
Experimental design
A randomised controlled trial of individuals undergoing
TJA for end-stage arthritis. Patients in the intervention
arm will undergo mindfulness training prior to TJA. Pa-
tients in the control arm will undergo TJA only. Outcomes
will be compared at 12 months after TJA. The study strat-
egy will be registered, constructed, and presented according
to the recommendations of the CONSORT statement [26].
Participants
Participants on the TJA waiting list at St. Vincent’s Hospital
Melbourne (SVHM) who present for pre-operative assess-
ment with moderate to severe psychological distress will
be invited to participate in the study. Pre-operative as-
sessment is conducted in the orthopaedic pre-admission
clinic at SVHM at which point physical and psychological
well-being scores are routinely captured using the Short
Form-12 (SF-12) questionnaire [27]. Attendance at the
orthopaedic pre-admission clinic is mandatory prior to TJA.
Here, patients undergo health assessment and education
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an orthopaedic surgeon, resident medical officer, and
nursing and allied health staff. After initial screening, po-
tentially suitable patients will be given a plain English
statement detailing the nature of the study and the com-
mitment required. For patients willing to proceed, informed
consent for the study will be obtained by the research
associate.
Inclusion
i) On the surgical waiting list for primary TJA for end-
stage osteoarthritis at SVHM.
ii) Presents with moderate to severe pre-operative
psychological distress (SF-12 MCS < 40). The SF-12
measures physical and psychological well-being
and is validated for use in the clinical setting and
Australian population. A score of less than 40 on
the mental component summary indicates moderate
psychological distress [27].
Exclusion
i) Revision surgery or surgery for neoplastic disease.
ii) Inability to provide informed consent due to mental
incompetence (e.g., intellectual disability, dementia;
mild cognitive impairment would not be cause for
exclusion).
iii)Active drug or alcohol use disorder which in the
opinion of the investigators makes the patient
unsuitable for participation in the trial.
iv) Limited English language fluency.
v) Evidence at interview or on the Memory Complaints
Questionnaire [28] of presumptive cognitive
impairment requiring clinical assessment.
Intervention
The intervention group will undergo MT prior to TJA,
with a ‘booster’ session at 3 months post-surgery. The
8-week program will be conducted on-site through the
Department of Psychiatry at SVHM by MBSR-qualified in-
vestigators and will be repeated every 10 weeks during the
recruitment phase. The program consists of: i) a personal
interview to establish rapport, undertake a brief psychi-
atric assessment and arrive at realistic goals; ii) weekly
group-based classes in mindfulness practice, 2 ½ hours,
10–20 participants, for 8 weeks plus a 7-hour Saturday
session in Week 6. MT is manualized with each class cov-
ering specific, predetermined MT exercises and topics.
Yoga based exercises are adapted to be performed in
either sitting or lying, to accommodate the potential mo-
bility limitations of the study population; iii) home-based
assignments to encourage regular practice of learned skills,
utilising a workbook and CDs with recorded meditationinstructions; iv) a post-intervention evaluation interview
of personal experiences, goal attainment, and future
maintenance of acquired skills; and v) a ‘booster’ day-long
workshop 3 months post-surgery. The rationale for this
‘booster’ session is based on a prior randomised trial in
which we found that improvements in pain and physical
function after TJA plateau by 6 months. Patients with
sub-optimal improvements in pain and physical function
at 6 months demonstrated a significant decline in their
mental well-being scores at 12 months compared to those
who experienced optimal physical function, whose mental
well-being scores were maintained [29].
Standard of care
Patients will undergo surgery and post-operative care as
per SVHM’s routine TJA program which has been stan-
dardised through the use of clinical pathway protocols
and validated in a randomised controlled trial [30]. Post-
discharge rehabilitation involves either an in-patient or home-
based physiotherapy program which is pre-determined during
pre-admission clinic assessment using a validated dis-
charge predictor tool [31]. Both programs are standardised
and conducted through SVHM’s in-patient or Hospital
In-The-Home service and are followed by referral to a
community-based physiotherapy program, based on the
locality of the patient’s residence. At a pre-admission
clinic, all patients receive an instruction booklet outlining
the continuum of care for TJA. All patients are reviewed
post-surgery in the same clinic at intervals of 6-weeks, 3-,
6-, and 12-months, and annually thereafter.
Outcome assessments
Data capture
Outcomes will be captured by the research associate.
Demographic information collected at baseline will in-
clude age, gender, co-morbidities, body mass index, and
socioeconomic data. We will also collect ‘time’ on the
waiting list. All MT sessions will be audio-taped and a
random sample will be selected and assessed for adher-
ence to the principles of MT. Fully-itemised costs of
healthcare will be captured via SVHM’s hospital net-
work, including administered medications as well as
costs of hospital in-patient and out-patient encounters.
While beyond the scope of the initial Discovery Project
time frame, the investigators will include a longer term
follow-up plan in the ethics application to allow scope
for continued data capture in the study group at the an-
nual outpatient review to 10 years.
Primary outcome
Will be self-reported pain and physical function measured
on the Western Ontario and McMaster Universities
(WOMAC) Osteoarthritis Index [32]. The WOMAC con-
sists of 24 items covering three subscales: pain (five items),
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*Assessments are given to patients at their surgical review visit but completed
independently. Assessments include: WOMAC; SF-12; WHOQOL-BREF; HADS;
Arthritis Self-Efficacy Scale; MAAS, Carver Brief COPE; Brief Illness Perceptions
Questionnaire; MMSE (administered at baseline during the pre-admission assessment).
+Applies to Attendance for Intervention Group Only.
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pain and physical function subscales will be used, each
subscale transformed to a score ranging from 0 to 100,
with a higher score indicating greater pain and physical
function. The WOMAC is a widely-used questionnaire
specifically designed to evaluate knee and hip osteoarth-
ritis [33,34].
Secondary outcomes
 Psychological well-being: will be derived from the
12-item Short Form Health Survey mental component
score [27].
 Quality of Life: will be measured using the
WHOQOL-BREF, a 26-item quality of life (QoL)
Assessment [35].
 Depression and anxiety: data will be derived from
the Hospital Anxiety and Depression Scale (HADS),
a validated instrument for detecting states of
depression and anxiety and severity of emotional
disorder in patients under treatment in hospital
medical, surgical, and outpatient departments [36].
 Self-efficacy: will be measured using the Arthritis
Self-Efficacy Scale, a 20-item questionnaire [37].
 Mindfulness: the Mindful Awareness Attention Scale
(MAAS) is a 15-item measure assessing mindfulness
and its role in psychological well-being [38].
 Carver brief COPE questionnaire: a 28-item
questionnaire to measure coping styles [39].
 Brief illness perceptions questionnaire: a 9-item
measure of illness perceptions [40].
 Irrational scale: a 20-item measure of cognitive
distortions [41].
 Health services utilisation: information regarding
utilisation of health services, including medications
and in- and outpatient services, will be captured by
linkage of our database to administrative and clinical
databases maintained by SVHM. The latter capture
extensive information on all healthcare encounters
(in-patient and out-patient) occurring at SVHM’s
hospital network, including administered medications
as well as fully-itemised costs of healthcare
encounters.
Additional measures
 The Mini-Mental State Exam (MMSE) [42]. This
short test is a commonly used screening instrument
of cognitive function with scores ranging from 0 to
30. MMSE scores lower than 24 are reliably associated
with the diagnosis of dementia or other organic
mental disorders. Although patients with frank
dementia will have been detected and excluded from
the study, it is possible that, in this patient population,some subjects will have previously unrecognised mild
degrees of cognitive impairment, and thus that
cognition may act as a confounder.
 Charlson Comorbidity Score [43]. This is a weighted
index for classifying comorbidities’ severity, validated
for estimating the risk of morbidity and mortality in
longitudinal studies.
 Self-reported past psychiatric history will be
obtained during the pre-surgery assessment to
account for previous psychological problems.
 Participants will be asked to rate their adherence to
mindfulness practice at 12 months through a
questionnaire that includes a Likert scale assessing
individual motivation to continue mindfulness
practice and questions regarding the average
amount of time (minutes) spent engaging in formal
and informal meditation.
Timelines
This is a 3-year study commencing June 2012 and ending
May 2015. See Table 1 and Figure 1 for time points and
recruitment progress.
Sample size
The sample size calculation was based on the following
parameters: i) alpha value = 0.05, 2-sided; ii) power =
80%; iii) expected rates of the primary outcome 1-year
post-TJA. To determine the sample size, we reviewed
the data from our SVHM joint registry from 2009 to
2010 [44]. Of 1,180 patients who underwent TJA, 40%
showed moderate to severe pre-operative psychological
distress according to the pre-operative SF-12 MCS score.
The mean difference in functional outcome scores at
12 months post-TJA between individuals with moderate
Figure 1 Trial flow diagram–first 12 months of study.
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viduals with no or mild psychological distress was 10
(+20) points. Based on these data, the sample size re-
quired in each of the 2 groups is 64. To allow for 15%
attrition, 150 patients will be recruited in total. These
numbers will also give more than 80% power to detect
the expected minimum clinically important difference in
pain and functional outcome scores between the com-
bined MT + TJA group and the TJA alone group.
Recruitment
Based on data from our registry, if we assume 40% of pa-
tients will present with moderate to severe psychological
distress and exclude patients who have a poor command
of English (10%), 450 patients would be eligible for inclu-
sion over a 20-month recruitment period. Presuming a
conservative recruitment rate of 1 in 3, target recruitment
is achievable within the study timeframe. Potential partici-
pants will receive both verbal and written information
about the requirements of participation including i) verbal
explanation of the program content upon initial contact
and ii) detailed outline of the program content and requiredcommitment in the patient information and consent form.
Consistent with our existing recruitment strategy for ran-
domised controlled trials, patients will receive i) written
material for study participants and ii) travel assistance and
telephone reminders of scheduled appointments; strategies
proven to improve recruitment and retention rates in
interventional studies [45]. Of importance and to avoid
bias, these strategies will be employed with patients in
both study arms.
Randomisation and masking
Following consent, block randomisation will be used to
determine which participant receives the intervention
according to a computer-generated random assignment
sequence prepared in advance. Considerable effort will
be made to avoid observer bias through separation of
roles and blinding of trial staff. A research assistant in-
dependent of patient recruitment and data collection
will be responsible for co-ordination of patient appoint-
ments, telephone reminders, and travel assistance. The
research associate (who will be responsible for patient
consent) will be blinded to group allocation. Mindfulness
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main blinded to outcome data throughout the study.
Upon completion of the study, a biostatistician blinded
to group allocation will analyse outcome data.
Data management
All data is stored on a password protected computer
kept in a secure locked facility and only accessible to the
Chief Investigators and Trial’s Coordinator as approved
by the SVHM Human Research Ethics Committee. At the
completion of the study, outcome data will be pooled and
de-identified for analysis by a statistician.
Statistical analysis
Statistical analysis will be by intention to treat. Categorical
variables will be analysed using χ2 tests (or Fisher’s Exact
test for small samples) while for continuous variables we
will employ (parametric) t-tests and (non-parametric)
Mann-Whitney tests for symmetrically and asymmetrically
distributed data, respectively. The significance of differences
in dichotomous data will be tested using generalised estimat-
ing equations or linear mixed model. If there are chance im-
balances in baseline patient characteristics hypothesised to
influence the main outcomes, then statistical techniques that
allow adjustment for confounding variables will be used as
secondary analyses. If there are more than 5% missing
data, sensitivity analyses allowing for different assump-
tions, such as the best or worst possible scenario, will
also be reported for the main outcomes of the study.
Health economic modelling will be applied to estimate
the potential cost-effectiveness of MT + TJA. Decision
analysis [46] will be used to compare the downstream
consequences of MT + TJA versus TJA alone. The in-
corporation of Markov [47] and life-tabling [48] tech-
niques will allow for the modelling of outcomes beyond
one year. The main output of interest in health eco-
nomic modelling is incremental cost-effectiveness ratios
in terms of net costs per unit of health gain. Net costs
will comprise the costs of MT + TJA minus costs saved
from the reduction in downstream health services
utilization. Health gains will be measured by estimating
years of life gained and quality-adjusted life years gained.
Both are enabled by the collection of time-to-outcome
data and the latter also by collection of QoL data. All
health economic analyses will be undertaken in accord-
ance with recommended approaches, such as 5% dis-
counting of estimated future costs and health gains. To
account for any uncertainty in the data inputs for health
economic modelling, sensitivity and uncertainty analyses
will be undertaken via Monte Carlo simulation [49].
Discussion
Experimental research on the ‘mechanism of action’ of
MT is still evolving, but there are good theoretical reasonsto suggest MT will be effective in this patient group. Our
clinical experience shows that despite much education
and informed consent, many patients have exaggerated,
unrealistic expectations of TJA, leading to greater postop-
erative dissatisfaction [50]. This often goes with a more
passive role in their own recovery, lower self-efficacy,
greater reliance on pain medication, and worse outcomes
generally, all often aggravated by having to wait long pe-
riods for the procedure. As MT teaches patients to come
to terms with unpleasant experiences without becoming
caught up in mental elaborations (e.g., disappointment or
anger), which accentuate the initial, unavoidable kernel of
suffering [25], it is likely to enhance acceptance of partial
symptomatic recovery. Physical rehabilitation is likely to
benefit from the greater awareness of body sensations and
limitations, as well as the confidence gained in exploring
those limits, encouraged by a number of MT methods
(notably ‘body scan’ and yoga) [51]. MT helps patients
come to terms with the pain as it is, rather than employing
distraction and pain reduction strategies which increas-
ingly are recognised to impair psychological function
when pain is chronic [52].
As already suggested, there is an extensive direct evi-
dence base for efficacy of MT in related conditions, such
as chronic pain [53]. Some of the earliest trials of MT in-
volved chronic pain patients, in whom it improved coping
and adaptation and reduced maladaptive illness behaviours
such as inappropriate health system utilisation [54]. Effect
sizes in studies of MT in general hospital settings compare
favourably with other psychological interventions; for ex-
ample, meta-analysis of studies in cancer patients found an
effect size (relative risk) of 0.48 for psychological and 0.18
for physical outcomes [55]. While broad in its application
and associated with accruing evidence for long-term func-
tional and quality of life benefits [21], there are as yet no
harmful side effects reported in MT.
While MT has been shown in numerous intervention
studies to enhance psychological and physiological well-
being in chronic disease populations [53], possible mecha-
nisms or mediators of these health outcomes have been
less well investigated [56]. In particular, little research has
addressed the connections between mindfulness and well-
established concepts in health psychology, such as illness
beliefs, cognitive distortions, and coping styles. A large
body of research shows that certain perceptions of illness
(e.g., perceived controllability) and cognitive distortions
(e.g., “life should be easier”, “to be worthwhile I must do
a thoroughly competent job in everything I do”) are associ-
ated with greater symptom reporting and reduced activity
[57], greater anxiety and depression [56,58,59], and re-
duced QoL [60]. Coping styles, that is, the ways in which
individuals try to manage challenges, have been identified
as the key mediator of the relationship between illness per-
ceptions, illness severity, and illness outcomes (such as
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on coping is complex, a key distinction is between ‘ap-
proach’ coping, generally associated with improved health
outcomes, and ‘avoidant’ coping, typically associated with
poorer health outcomes [56].
To date, only one published study has specifically eval-
uated the influence of MT on coping styles and possible
mediating cognitive processes [56]. Using a sample of 57
students, the authors found that after 12 weeks of mind-
fulness classes, cognitive distortions, approach coping,
and positive affect increased, while avoidance coping
and anxiety and negative affect decreased. Encouraging
as these results may be, their applicability to an older,
physically unwell, and psychologically troubled popula-
tion remains an open question.
Given the efficacy of MT, the lack of information
about its effects on well-established mediators of illness
outcomes is an important gap in the literature. Thus, an
important research question is the extent to which the
beneficial impact of MT on illness outcomes may be due
to changes in individual illness perceptions, cognitive
distortions, and coping styles. Our exploratory investiga-
tion of this question will help guide future mindfulness-
based interventions and research.
This study will use a mindfulness-based psychological
intervention to enhance outcomes in people undergoing
total joint replacement and, in so doing, will test hypotheses
about coping with chronic illness in an aged population.
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